OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection
Maria Luisa Faquetti, Francesca Grisoni, Petra Schneider, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9

Showing 9 citing articles:

JAK inhibitor selectivity: new opportunities, better drugs?
Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 649-665
Closed Access | Times Cited: 18

Differential properties of Janus kinase inhibitors in the treatment of immune-mediated inflammatory diseases
Peter C. Taylor, Ernest Choy, Xenofon Baraliakos, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 2, pp. 298-308
Open Access | Times Cited: 32

Baricitinib and tofacitinib off‐target profile, with a focus on Alzheimer's disease
Maria Luisa Faquetti, Laura Slappendel, Hélène Bigonne, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5

Computer-Aided Drug Design of Novel Derivatives of 2-Amino-7,9-dihydro-8H-purin-8-one as Potent Pan-Janus JAK3 Inhibitors
Abdelmoujoud Faris, Ibrahim M. Ibrahim, Omkulthom Al Kamaly, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5914-5914
Open Access | Times Cited: 8

CoGT: Ensemble Machine Learning Method and Its Application on JAK Inhibitor Discovery
Yingzi Bu, Ruoxi Gao, Bohan Zhang, et al.
ACS Omega (2023) Vol. 8, Iss. 14, pp. 13232-13242
Open Access | Times Cited: 4

Cardiovascular Risk Management in Patients Treated With Janus Kinase Inhibitors
Jill Shah, Keya Shah, Alisa N. Femia, et al.
Journal of Cardiovascular Pharmacology (2023) Vol. 83, Iss. 5, pp. 392-402
Closed Access | Times Cited: 4

Atopic Dermatitis and Abrocitinib: Unraveling the Therapeutic Potential
Ayesha Abdul Qadir Memon, Habibun Nisa, Muhammad Osama, et al.
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 2
Closed Access

Non-Kinase Off-Target Inhibitory Activities of Clinically-Relevant Kinase Inhibitors
Nickolas R. Brauer, Allison L. Kempen, Delmis E. Hernandez, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116540-116540
Closed Access

Page 1

Scroll to top